1. Home
  2. DERM vs DOUG Comparison

DERM vs DOUG Comparison

Compare DERM & DOUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Journey Medical Corporation

DERM

Journey Medical Corporation

HOLD

Current Price

$7.11

Market Cap

194.9M

Sector

Health Care

ML Signal

HOLD

Logo Douglas Elliman Inc.

DOUG

Douglas Elliman Inc.

HOLD

Current Price

$1.97

Market Cap

162.3M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
DERM
DOUG
Founded
2014
1911
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building operators
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
194.9M
162.3M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
DERM
DOUG
Price
$7.11
$1.97
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$12.67
N/A
AVG Volume (30 Days)
338.9K
382.5K
Earning Date
05-13-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
34.72
118.68
EPS
N/A
N/A
Revenue
$61,858,000.00
$955,578,000.00
Revenue This Year
$39.72
N/A
Revenue Next Year
$63.24
N/A
P/E Ratio
N/A
N/A
Revenue Growth
10.20
N/A
52 Week Low
$4.31
$1.53
52 Week High
$9.56
$3.19

Technical Indicators

Market Signals
Indicator
DERM
DOUG
Relative Strength Index (RSI) 63.54 65.48
Support Level $7.00 $1.55
Resistance Level $7.69 $2.06
Average True Range (ATR) 0.44 0.08
MACD 0.06 0.02
Stochastic Oscillator 86.21 77.63

Price Performance

Historical Comparison
DERM
DOUG

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

About DOUG Douglas Elliman Inc.

Douglas Elliman Inc is engaged in the real estate services business and seeks to acquire or invest in additional real estate services businesses. The Company also offers, through its subsidiaries and ventures, development marketing services and ancillary services, including mortgage, title, and escrow services. It generates revenue from commissions and other brokerage income, property management, and other ancillary services.

Share on Social Networks: